Navigation Links
Embryonic Cells Might Prevent Parkinson’s Disease From Worsenin

Patients with Parkinson’s disease may be able to stop or even slightly improve the progression of the disease if they undergo a surgical procedure to implant // embryonic cells into their brains, say researchers. The cells work by producing dopamine, a neurochemical that helps control movement. People with Parkinson’s don’t produce enough dopamine, which leads to the movement problems common in people with the condition.

Researchers compared 20 patients who had cells implanted with 19 patients who underwent a sham surgery for comparison purposes. All were tested for movement problems before the surgery and then again four months and 12 months later. Researchers then compared the scores between the two groups.

Results showed increasingly different scores for the two groups over time, with the greatest differences attributed to steadily worsening scores in the patients who did not receive the cell implants. Patients age 60 and older had the worst outcomes. Researchers believe the cell implants may have helped stabilize the brains of the patients who received them, suggesting the treatment could keep Parkinson’s disease from worsening.

Specialists say that this is an important beginning and they suggest additional studies in the area may one day lead to “highly specific and effective new genomic-based therapies.?
'"/>




Page: 1

Related medicine news :

1. Embryonic Genetic Testing Is Boosting IVF Pregnancies
2. T-cells Developed from Human Embryonic Stem Cells
3. Treatment of Spinal Cord Injury with Embryonic Stem Cells
4. Human Embryonic Stem Cells Could Be Later Used In Therapeutic Cloning
5. Researchers Create Genetically-Matched Embryonic Stem Cells for Transplantation
6. Embryonic Selection of Sex can Avoid Conceiving Blind Children
7. Lipid Plays Big Role in Embryonic Development
8. Blood Cells Capable of Regenerating Liver
9. White Cells Count Can Predict Heart Attack Death Risk
10. Gene Therapy Destroys Pancreatic Cancer Cells
11. Stem Cells Have Few Mutations
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2017)... ... ... Month and the focus is on prostate cancer. Second only to skin cancer, prostate ... common cause of cancer related death today; lung cancer remains in the number one spot. ... during his lifetime. Those at highest risk are men who have a family ...
(Date:6/24/2017)... ... ... Doorknobs are for convenience, deadbolts are for security. , There are many ... an alarm system installed. But unless there is a working deadbolt lock that is ... Premier Locksmith in Killeen, TX says: “In the majority of home burglaries, intruders use ...
(Date:6/23/2017)... ... June 24, 2017 , ... Studies show evidence that carotenoids and antioxidants derived ... loss in these patients. , But how often do ophthalmologists and optometrists in Sweden ... at risk of or with early symptoms of AMD? A study published recently ...
(Date:6/23/2017)... ... ... Goodcents Deli Fresh Subs today announced the opening of a new restaurant ... Topeka, Kan. 66604 (near 21st and Gage). It is owned and operated by long-time ... in the Topeka and Bonner Springs, Kan. area. , “Goodcents has such a ...
(Date:6/23/2017)... ... June 23, 2017 , ... MD Now Urgent ... is MD Now’s 28th facility overall and marks the urgent care center's eighth location ... mile North of The Falls shopping mall. The new clinic offers a wide array ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... 7, 2017  Novavax, Inc., (Nasdaq: NVAX ) ... 2 trials of its RSV F protein recombinant nanoparticle vaccine ... have been published in the journal Vaccine ... in prior scientific conferences). The Company previously announced top ... is developing the RSV F Vaccine with the goal of ...
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
(Date:5/29/2017)... -- Cellect Biotechnology Ltd. (NASDAQ: APOP ; TASE: APOP), ... selection of stem cells, today provided a corporate update ... March 31 st , 2017. "We ... quarter of 2017," said Dr. Shai Yarkoni, Chief Executive ... of the first blood cancer patient in the recently ...
Breaking Medicine Technology: